Type 1 Diabetes, Pregnancy
Conditions
Keywords
Type 1 diabetes, Pregnancy, Glycemic variability, Between visit contact
Brief summary
Hypothesis: Increased contact with the diabetes care team throughout pregnancy will lead to improved glucose control during pregnancy.
Detailed description
Patient will have weekly contact through the Mayo Patient On-line Services to send in their blood glucose readings and to receive recommendations back regarding insulin dose changes. Information will be analyzed regarding the magnitude of change in insulin dosing and in glycemic variability.
Interventions
OTHERFrequent remote contact between clinic visits.
Subjects will upload diabetes device data onto websites. Website data will be reviewed by study team who will provide feedback to patients without clinic visits.
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Patients were provided help with insulin pump and CGM between visits throughout the pregnancy.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* Adult pregnant women with type 1 diabetes utilizing either an insulin pump or multiple daily injection insulin program to manage their diabetes Inclusion Criteria: * Female with type 1 diabetes and pregnancy * EDD prior to November 15, 2014 * 18 years of age and older * On insulin pump or multiple daily injection insulin program * Signed patient consent form
Exclusion criteria
*
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glucose variability | Baseline to 9 months | Glucose variability represented by multiple measures including mean plasma glucose with standard deviation, high blood glucose index, low blood glucose index and average daily risk range. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes is severe hypoglycemia | up to 9 months | Severe hypoglycemic events |
Countries
United States
Outcome results
None listed